Introduction {#sec1-1}
============

Neural circuit damage or neurotransmitter loss induced by neuronal cell degeneration or necrosis in local brain areas is the pathological basis for neurological diseases (Zhang et al., 2014a; Masoudian et al., 2015; McHugh and Buckley, 2015). Currently, the main method for treatment of these diseases is supplementation of neurotransmitters that are reduced because of neuronal loss (Dineley et al., 2015; Levin et al., 2015; Li et al., 2015). However, this approach does not fundamentally solve the problem of neuronal degeneration and necrosis.

Currently, stem cell transplantation for the treatment of nervous system diseases is attracting many researchers' attention (Buzhor et al., 2014; Nicaise et al., 2015; Tong et al., 2015), as stem cells exhibit the potential of multi-lineage differentiation (Komaki et al., 2014; Ren et al., 2015). Neural stem cells (NSCs) are a type of stem cells that are present not only in embryonic tissue (Tsai et al., 2014; Gao et al., 2015) but in adult mammals in the subventricular zone of the lateral ventricles (Boccazzi et al., 2014; Li et al., 2014; Tong et al., 2014), subgranular zone of the dentate gyrus (Clarke and van der Kooy, 2011; Guo et al., 2012; Schultheiß et al., 2013), and even the spinal cord (Xu et al., 2012), striatum (Conway and Schaffer, 2014), and hypothalamus (Rojczyk-Gołębiewska et al., 2014). As these cells exhibit the potential of multi-lineage differentiation, they can differentiate into neurons (Cai et al., 2014; Ramos et al., 2015; Wang et al., 2015), oligodendrocytes (Azim et al., 2014; Shi et al., 2014; Shirazi et al., 2015), and astrocytes (Falcone et al., 2015; Han et al., 2015). Therefore, NSCs are considered to be an ideal cell source to treat neurodegenerative diseases. Research shows that under endogenous conditions, the vast majority of NSCs differentiate into glial cells *in vivo* and *in vitro*, and only a few differentiate into neurons. External factors such as glial cell-derived neurotrophic factor (Deng et al., 2013), retinoic acid (Gu et al., 2015), nerve growth factor, and brain-derived neurotrophic factor (Liu et al., 2014a) more readily promote differentiation of NSCs into neurons, however the number of neurons is too small to meet the requirements of clinical treatment. Thus, investigation of the molecular mechanisms and additional factors involved during NSC differentiation into neurons is urgently needed.

In our previous studies, we established a rat model of hippocampal denervation by fimbria-fornix (FiFx) transection, and transplanted subventricular zone-derived NSCs into the hippocampus of this model. We found that within a certain time period, the implanted NSCs were more likely to survive and differentiate into neurons (Zhang et al., 2007). Next, we cultured hippocampal NSCs obtained from fetal rats with denervated hippocampal extracts, and found that this significantly promoted *in vitro* differentiation of NSCs into neurons (Zhang et al., 2009). These results suggest that during a certain time period after denervation, the hippocampal microenvironment provides favorable conditions for NSCs to survive, regenerate, and differentiate into neurons. Nevertheless, the process remains poorly understood, including the number of factors involved.

Our previous study also found that during a certain time period after denervation, expression of insulin like growth factor-1 and ciliary neurotrophic factor (CNTF) are both up-regulated in the denervated hippocampus. Furthermore, we confirmed that insulin like growth factor-1 induces hippocampal NSCs derived from fetal rats to differentiate *in vitro* into neurons via the PI3K/Akt pathway (Zhang et al., 2014b). In this study, cultured rat embryonic hippocampal NSCs were cultured with CNTF *in vitro* to determine if CNTF plays a similar role to insulin like growth factor-1.

Materials and Methods {#sec1-2}
=====================

Ethics statement and animals {#sec2-1}
----------------------------

Animal studies were approved by the committee for Institutional Animal Care and Use Committee of Nantong University, China, and performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Precautions were taken to minimize suffering and the number of animals used in each experiment. Twelve healthy adult female specific pathogen-free Sprague-Dawley rats weighing 200--250 g, and three pregnant Sprague-Dawley rats at embryonic day 17 (E17) were purchased from the Animal Research Center of Nantong University of China (license No. SYXK (Su) 2012-0031).

Establishment of a hippocampal denervation model by FiFx transection {#sec2-2}
--------------------------------------------------------------------

Right FiFx transection was performed as described previously (Zou et al., 2010). In brief, rats were intraperitoneally anesthetized with chloral hydrate (2 mL/kg) and fixed in a stereotaxic instrument (Zhenghua, Anhui Province, China). The skull periosteum was separated, and anterior fontanelle coordinates recorded. According to the atlas of Paxinos and Watson (1986), two points were located on the right side of the skull: anterior (sagittal axis) = 1.4 mm, lateral (coronal axis) = 1.0 mm; and anterior = 1.4 mm, lateral = 4.0 mm (Zou et al., 2010). An aperture was drilled between these two points and a wire-knife lowered to a depth of 5.4 mm ventral to the dura. The knife was shifted back and forth three times before slowly being withdrawn from the brain. The left side of the hippocampus was not operated on, and therefore representative of the normal condition (*i.e.*, control). After surgery, rats were caged with free access to food and water.

Nissl staining {#sec2-3}
--------------

Seven days after surgery, three rats were intraperitoneally anesthetized with chloral hydrate (2 mL/kg) and successively perfused with 0.9% (w/v) NaCl and 4% (w/v) paraformaldehyde. To determine if the right denervated hippocampal model had been successfully established, coronal sections (20 mm) surrounding FiFx were prepared and subjected to Nissl staining. Sections were soaked in dimethylbenzene (two times), 100% alcohol (two times), 95% alcohol, 70% alcohol, and water for 5 minutes each step. Subsequently, sections were stained with 0.1% cresyl violet for 20 minutes, washed with water, and viewed using a phase contrast microscope (Leica, Heidelberg, Germany).

Western blot assay {#sec2-4}
------------------

Whole hippocampi were rapidly removed from three FiFx transected rats. Total protein was extracted from normal and denervated hippocampi using mammalian Protein Extraction Reagent (Pierce, Waltham, MA, USA). Equivalent amounts of protein (30 μg) were loaded and separated on 10% sodium dodecyl sulfate-polyacrylamide gels before transfer to polyvinylidene difluoride membranes (Bio-Rad, Hercules, CA, USA). Membranes were blocked with 5% non-fat milk in Tris-buffered saline (Sangon, Shanghai, China), incubated overnight at 4°C with primary antibodies (rabbit polyclonal anti-CNTF: 1:1,000, Abcam, Cambridge, UK; mouse monoclonal anti-β-actin: 1:10,000, Sigma, St. Louis, MO, USA), and then secondary antibodies (horseradish peroxidase-conjugated goat anti-mouse IgG, 1:1,000, Pierce; horseradish peroxidase-conjugated goat anti-rabbit IgG, 1:1,000, Pierce) for 2 hours at room temperature. Finally, complexes were visualized by enhanced chemiluminescence (Santa Cruz Biotechnology, Santa Cruz, CA, USA) after X-ray exposure (Kodak, Rochester, NY, USA). The gray scale of each band was scanned and quantified using the Shine-tech Image System (Shanghai, China).

Reverse transcription-polymerase chain reaction (RT-PCR) {#sec2-5}
--------------------------------------------------------

Hippocampi were dissected from three FiFx transected rats and total RNA extracted using a Trizol reagent kit (BBI, Markham, Canada). Two μg of total RNA was reverse transcribed into cDNA using oligo (dT) primers and Omniscript reverse transcriptase (QIAGEN, Hilden, Germany), according to the manufacturer\'s instructions. RT-PCR was performed using the following primers (synthesized by Sangon, Shanghai, China): CNTF: forward, 5′-GGA CCT CTG TAG CCG TTC TA-3′, reverse, 5′-TCA TCT CAC TCC AAC GAT CA-3′; and GAPDH: forward, 5′-ACC ACA GTC CAT GCC ATC AC-3′, reverse, 5′-TCC ACC CTG TTG CTG TA-3′. PCR products were separated by agarose gel electrophoresis and then ethidium bromide stained. Optical density of the CNTF band relative to the GAPDH band was determined using an image analysis system (Leica Q550I W).

Enzyme-linked immunosorbent assay (ELISA) {#sec2-6}
-----------------------------------------

Normal (left) and denervated (right) hippocampi were removed from FiFx transected rats, placed into an aseptic glass-homogenizer with cold Dulbecco\'s modified Eagle\'s medium (DMEM, 1 mL/100 mg; Gibco, Grand Island, NY, USA), and homogenized for 10 minutes. Homogenates were centrifuged at 4°C 250 × *g* for 5 minutes. Supernatants were harvested and the amount of CNTF was determined using a rat CNTF ELISA kit (R&D, Minneapolis, MN, USA), according to the manufacturer\'s instruction.

NSC culture and neuronal differentiation {#sec2-7}
----------------------------------------

NSCs were derived from hippocampi of fetal (E17) rats, as described previously (Zhang et al., 2009). In brief, hippocampi were rapidly dissected into 1.5 mL eppendorf tubes containing 0.125% trypsin and mechanically dissociated to single-cell suspensions. These suspensions were centrifuged at 250 × *g* for 5 minutes and the supernatants discarded. Single cells were cultured in 50 cm^2^ flasks at a density of 1 × 10^4^ cells/mL, with 5 mL NSC culture medium (DMEM/F12 medium (1:1; Gibco), 2% B27 (Gibco), 10 ng/mL epidermal growth factor (Gibco), 10 ng/mL basic fibroblast growth factor (Sigma), and 100 U/mL penicillin/streptomycin) in a humidified 95% air 5% (v/v) CO~2~ incubator at 37°C. Five days later, neurospheres were dissociated into single-cell suspensions and seeded into 96-well plates at 1--2 cells per well. Subclonal neurospheres were digested and passaged as before. Cells were passaged three times to obtain neurospheres that originated from single primary cells. On the third passage, neurospheres were rinsed in DMEM and digested into single cells using 0.125% trypsin. Single NSCs were seeded at a density of 5 × 10^5^ cells/mL into poly-L-lysine-coated 24-well plates containing differentiation medium (DMEM/F12, 2% fetal bovine serum, and 100 U/mL penicillin/streptomycin). NSCs were cultured without CNTF (control group) or with conditional medium containing 10 ng/mL CNTF (Sigma; CNTF group). After 7 days, differentiation was terminated and cells were detected by immunofluorescence assay.

Immunofluorescence assay {#sec2-8}
------------------------

Microtubule associated protein-2 (MAP2) is a marker of mature neurons (Nakano et al., 2015; Razavi et al., 2015) and glial fibrillary acidic protein (GFAP) a marker of glial cells (Babaee et al., 2015; Pacey et al., 2015). Cells were washed twice with ice-cold phosphate buffered saline (PBS), fixed with 100% methanol for 7 minutes at −20°C, and permeated with fresh 4% paraformaldehyde for 20 minutes at room temperature. Cells were blocked with blocking buffer (10% goat serum in PBS containing 0.3% Triton X-100 and 0.03% NaN~3~) overnight at 4°C. Next, cells were incubated at 4°C for 24 hours with primary antibody diluted in blocking buffer, followed by incubation overnight at 4°C with secondary antibody diluted in blocking buffer. After washing with PBS, cells were stained with Hoechst 33342 (1:1,000; Pierce) for 30 minutes at room temperature and then viewed using a fluorescence microscope (Leica). The primary antibodies used were: mouse monoclonal anti-MAP2 (1:1,000; Millipore, Boston, MA, USA) and rabbit polyclonal anti-GFAP (1:500; Sigma). The secondary antibodies used were: Alexa Fluor 568-conjugated (red) goat anti-rabbit IgG (1:500; Invitrogen, Carlsbad, CA, USA) and Alexa Fluor 488-conjugated (green) goat anti-mouse IgG (1:200; Invitrogen).

Statistical analysis {#sec2-9}
--------------------

Data are expressed as the mean ± SEM. All statistical evaluations were performed using a two-tailed Student\'s *t*-test, and data were analyzed using SPSS 11.0 software (SPSS, Chicago, IL, USA). A probability level of *P* \< 0.05 was considered to be significant.

Results {#sec1-3}
=======

FiFx transection in the adult rat hippocampus {#sec2-10}
---------------------------------------------

Nissl staining confirmed complete dissection of the right FiFx, while the left side remained intact (**[Figure 1](#F1){ref-type="fig"}**). This indicates successful establishment of our denervated hippocampal model.

![Nissl staining of a coronal brain section showing dissection of the right transected FiFx.\
Circles show complete loss of the right FiFx, while the left FiFx remains intact. Scale bar: 300 μm. FiFx: Fimbria-fornix.](NRR-11-597-g002){#F1}

CNTF expression in denervated hippocampus {#sec2-11}
-----------------------------------------

Seven days after right FiFx transection, CNTF mRNA and protein levels in normal and denervated hippocampi were examined by RT-PCR analysis (**Figure [2A](#F2){ref-type="fig"}, [B](#F2){ref-type="fig"}**), western blot assay (**Figure [2C](#F2){ref-type="fig"}, [D](#F2){ref-type="fig"}**), and ELISA (**[Figure 2E](#F2){ref-type="fig"}**). Compared with normal hippocampus, both CNTF mRNA and protein levels in denervated hippocampus were significantly up-regulated.

![Expression of endogenous CNTF mRNA and protein in normal and the denervated hippocampi 7 days after right FiFx transection.\
(A) mRNA levels of CNTF (161 bp) and GAPDH (452 bp, as a reference) detected by RT-PCR. (B) Quantification of CNTF mRNA. Relative expression was expressed as the optical density ratio of CNTF to GAPDH. (C) Western blot assay of protein levels of CNTF and β-actin (as a reference). The molecular weight of CNTF and β-actin are 24 kDa and 42 kDa, respectively. (D) Quantification of CNTF protein. Relative expression was expressed as the optical density ratio of CNTF to β-actin. (E) ELISA identified CNTF protein levels in normal and denervated hippocampi. Data are expressed as the mean ± SEM. \**P* \< 0.05, \*\**P* \< 0.01, *vs*. normal hippocampus (two-tailed Student\'s *t*-test, *n* = 3). CNTF: Ciliary neurotrophic factor; RT-PCR: reverse transcription-polymerase chain reaction; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; ELISA: enzyme linked immunosorbent assay; FiFx: fimbria-fornix.](NRR-11-597-g003){#F2}

Neuronal differentiation of hippocampal NSCs treated *in vitro* with CNTF {#sec2-12}
-------------------------------------------------------------------------

After 7 days of differentiation, immunofluorescence showed increased MAP2-positive cell number and decreased GFAP-positive cell number in the CNTF group compared with the control group (**[Figure 3](#F3){ref-type="fig"}**).

![Immunofluorescence analysis of MAP2 and GFAP expression in hippocampal NSCs derived from embryonic day 17 fetal rats.\
(A) Cells were separately stained for GFAP (red) and MAP2 (green), with total cell number indicated by Hoechst (blue). Scale bar: 20 µm. (B) MAP2-positive cells are indicated by a percentage of total cells. (C) GFAP-positive cells are indicated by a percentage of total cells. Data are the mean ± SEM. Experiments were performed in triplicate. \**P* \< 0.05, \*\**P* \< 0.01, *vs*. control (two-tailed Student\'s *t*-test). MAP2: Microtubule associated protein-2; GFAP: glial fibrillary acidic protein; CNTF: ciliary neurotrophic factor.](NRR-11-597-g004){#F3}

Discussion {#sec1-4}
==========

Recently, an increasing number of studies reported that because of their potential for neuronal differentiation, NSCs are a good cell source for cell therapy of neurodegenerative diseases (Diamandis et al., 2007; Marutle et al., 2007). However, to date, the number of neurons obtained from NSCs using various *in vitro* methods is too small to meet the demands of therapy (Donato et al., 2007; Yi et al., 2008). Thus, to induce differentiation of a sufficient number of neurons from NSCs, and subsequently meet the demands of clinical treatment, further study of the molecular mechanisms underlying neuronal differentiation of NSCs is urgently needed.

Our previous studies have shown that denervating the hippocampus by FiFx transection enables both grafted and endogenous newborn NSCs to proliferate, migrate, and differentiate into neurons in the hippocampus (Zhang et al., 2007; Zou et al., 2010). These indicates that the denervated hippocampus may provide a favorable environment for neuronal differentiation of NSCs. However, the pathways and mechanisms in this process are still unclear.

Here, we show that compared with the normal hippocampus, expression of both CNTF mRNA and protein in the denervated hippocampus is significantly up-regulated 7 days after right FiFx transection. CNTF was first reported as a survival factor in ciliary ganglion neurons of chick embryos. It has since been shown that CNTF activates a receptor complex composed of a ligand-binding α-subunit (CNTF Rα) and two signal transducing β-subunits (LIFRβ and gp130) (Inoue et al., 1996). Further studies have shown that CNTF plays a similar role in many other nervous system cells, for example motor neurons (Lamas et al., 2014), sensory neurons (Bailey and Green, 2014), and sympathetic ganglion neurons (Saygili et al., 2011). DeWitt et al. (2014) reported that CNTF promotes neuronal differentiation and cell cycle withdrawal in neuroblastoma cells. Nilbratt et al. (2010) found that CNTF promotes differentiation of human embryonic stem cells into cholinergic neurons. Thus, we hypothesized that increased CNTF in the denervated hippocampus microenvironment might lead to neuronal differentiation of endogenous hippocampal NSCs. To examine this, we cultured hippocampal NSCs derived from E17 fetal rats with exogenous human CNTF for 7 days *in vitro*, and found that approximately 8.19 ± 0.79% cells were MAP2-positive. In contrast, cells cultured in medium without CNTF, resulted in almost no MAP2-positive cells. Instead, the vast majority of cells showed GFAP-positive expression. These results indicate that CNTF promotes a portion of NSCs to differentiate into neurons, while in the absence of CNTF (and any other neurotrophic factors), the vast majority of NSCs spontaneously differentiate into glial cells *in vitro*. Thus, we speculate that CNTF may be one of the factors that promotes neuronal differentiation of endogenous NSCs in the denervated hippocampus. It is still unclear how up-regulated hippocampal CNTF promotes NSC differentiation into neurons after FiFx transection. Many studies have shown two main CNTF-related signaling pathways. Vigneswara et al. (2014) reported that CNTF reduces apoptosis of retinal ganglion cells through the JAK/STAT signaling pathway. Moreover, other studies have shown that CNTF participates in neuronal migration and neurite outgrowth of the dorsal root ganglion through the PI3K/Akt and JAK2/STAT3 signaling pathways (Liu et al., 2014b). Therefore, in future studies, we will determine if endogenous CNTF promotes neuronal differentiation of hippocampal NSCs in the denervated hippocampus *via* these two signaling pathways *in vivo*. Of course, there may be other signaling pathways involved in this process.

In the present study, the neuronal differentiation efficiency of hippocampal NSCs induced by CNTF *in vitro* was still low. Based on these findings, we speculate that the denervated hippocampus promotes expression of endogenous CNTF and upregulated CNTF may be involved in hippocampal NSC differentiation into neurons *in vivo*. These changes may be beneficial to repair and regeneration of the hippocampus after injury. Although the molecular mechanisms of this phenomenon have not yet been fully confirmed, our findings provide the experimental basis for neuronal differentiation of NSCs with CNTF. These findings may help to promote the clinical application of cell replacement therapy.
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